InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the detailed record of transactions filed by Aromando, Andrew P.. Director active across 1 company, notably Oncolytics Biotech Inc.. In total, 1 reports have been logged. Activity tracked since 1 June 2026. The latest transaction was disclosed on 1 June 2026 (50 - Grant of options). Regulator: SEDI. The full history is openly available.
1 of 1 declaration